T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Sign
- Corax Consultants LLC
- 12. Apr. 2024
- 1 Min. Lesezeit
T-cell therapy developer, Cbio A/S cecures DKK40M in Financing to enter clinical stage in cervical cancer T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured
Kommentare